• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Non-operative therapies for colorectal liver metastases.结直肠癌肝转移的非手术治疗方法。
J Gastrointest Oncol. 2015 Apr;6(2):224-40. doi: 10.3978/j.issn.2078-6891.2014.065.
2
Locoregional Therapies for Colorectal Cancer Liver Metastases: Options Beyond Resection.结直肠癌肝转移的局部区域治疗:除切除术之外的选择。
Am Soc Clin Oncol Educ Book. 2021 Mar;41:133-146. doi: 10.1200/EDBK_320519.
3
Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT.局限性肝或肺结直肠癌转移。全身治疗、手术、消融或立体定向体部放疗。
J Clin Med. 2021 May 14;10(10):2131. doi: 10.3390/jcm10102131.
4
Local therapies for hepatic metastases.肝脏转移瘤的局部治疗。
J Natl Compr Canc Netw. 2013 Feb 1;11(2):153-60. doi: 10.6004/jnccn.2013.0023.
5
Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities.结直肠癌肝转移的局部区域治疗:动脉内化疗的可能性及新的肝脏靶向治疗方式
Hepatogastroenterology. 2001 Mar-Apr;48(38):305-12.
6
Multimodal Management of Colorectal Liver Metastases: State of the Art.结直肠癌肝转移的多模式管理:最新进展
Oncol Rev. 2024 Jan 4;17:11799. doi: 10.3389/or.2023.11799. eCollection 2023.
7
Treatments for colorectal liver metastases: A new focus on a familiar concept.结直肠癌肝转移的治疗:对一个熟悉概念的新关注。
Crit Rev Oncol Hematol. 2016 Dec;108:154-163. doi: 10.1016/j.critrevonc.2016.11.005. Epub 2016 Nov 16.
8
WITHDRAWN: Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases.撤回:结直肠癌肝转移的手术切除与不干预或其他手术干预的比较
Cochrane Database Syst Rev. 2007 Oct 17(4):CD006039. doi: 10.1002/14651858.CD006039.pub3.
9
WITHDRAWN: Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases.撤回:结直肠癌肝转移的手术切除与不干预或其他手术干预的比较
Cochrane Database Syst Rev. 2007 Jul 18(3):CD006039. doi: 10.1002/14651858.CD006039.pub2.
10
Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies?在全身靶向治疗时代,肝局部区域治疗在转移性神经内分泌肿瘤的治疗中是否仍有作用?
World J Gastroenterol. 2017 Apr 21;23(15):2640-2650. doi: 10.3748/wjg.v23.i15.2640.

引用本文的文献

1
Right Hepatic and Portal Vein Embolization before Right Hepatectomy for Colorectal Cancer Liver Metastases.结直肠癌肝转移患者右半肝切除术前的右肝及门静脉栓塞术
Case Rep Gastroenterol. 2023 May 30;17(1):212-220. doi: 10.1159/000529909. eCollection 2023 Jan-Dec.
2
Identifying Optimal Surgical Intervention-Based Chemotherapy for Gastric Cancer Patients With Liver Metastases.确定针对伴有肝转移的胃癌患者的基于最佳手术干预的化疗方案。
Front Oncol. 2021 Nov 29;11:675870. doi: 10.3389/fonc.2021.675870. eCollection 2021.
3
Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist.不可切除的结直肠癌转移患者的局部治疗:肿瘤内科医生视角的综述
Cancers (Basel). 2021 Nov 25;13(23):5938. doi: 10.3390/cancers13235938.
4
The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials.癌症干细胞在结直肠癌中的作用:从基础到新型临床试验
Cancers (Basel). 2021 Mar 4;13(5):1092. doi: 10.3390/cancers13051092.
5
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.立体定向体部放疗在肝转移瘤治疗中的作用:临床结果和预后因素。
Strahlenther Onkol. 2020 Apr;196(4):325-333. doi: 10.1007/s00066-019-01524-8. Epub 2019 Oct 11.
6
Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.基线 3D-ADC 比 2D-ADC 更能预测结直肠癌肝转移患者对治疗的反应。
Eur Radiol. 2020 Jan;30(1):291-300. doi: 10.1007/s00330-019-06289-3. Epub 2019 Jun 17.
7
Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018).中国结直肠癌肝转移诊断和综合治疗指南(2018 版)。
J Cancer Res Clin Oncol. 2019 Mar;145(3):725-736. doi: 10.1007/s00432-018-2795-1. Epub 2018 Dec 12.
8
Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases.钇-90放射性栓塞治疗结直肠癌肝转移后生存的预测因素
J Vasc Interv Radiol. 2018 Aug;29(8):1094-1100. doi: 10.1016/j.jvir.2018.02.020. Epub 2018 May 10.
9
Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis.迈耶通过调节氧化应激和细胞凋亡来预防辐射诱导的肝损伤。
J Ginseng Res. 2017 Apr;41(2):159-168. doi: 10.1016/j.jgr.2016.02.006. Epub 2016 Mar 3.

本文引用的文献

1
Intra-arterial therapies for metastatic colorectal cancer.转移性结直肠癌的动脉内治疗
Semin Intervent Radiol. 2013 Mar;30(1):12-20. doi: 10.1055/s-0033-1333649.
2
Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer.一项 FOLFIRI{+/-}panitumumab 二线治疗转移性结直肠癌的随机 3 期研究的最终结果。
Ann Oncol. 2014 Jan;25(1):107-16. doi: 10.1093/annonc/mdt523.
3
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial.阿柏西普联合氟尿嘧啶、亚叶酸钙和伊立替康治疗既往治疗的转移性结直肠癌:VELOUR 试验的预先指定亚组分析。
Eur J Cancer. 2014 Jan;50(2):320-31. doi: 10.1016/j.ejca.2013.09.013. Epub 2013 Oct 16.
4
Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.经动脉化疗栓塞术联合伊立替康微球治疗结直肠癌肝转移:系统评价。
J Vasc Interv Radiol. 2013 Aug;24(8):1209-17. doi: 10.1016/j.jvir.2013.05.055.
5
Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.经皮射频消融治疗小肝结直肠转移瘤:最长 10 年随访的局部反应率和长期生存率。
Radiology. 2012 Dec;265(3):958-68. doi: 10.1148/radiol.12111851. Epub 2012 Oct 22.
6
Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis.射频消融与切除术治疗结直肠癌肝转移:荟萃分析。
PLoS One. 2012;7(9):e45493. doi: 10.1371/journal.pone.0045493. Epub 2012 Sep 21.
7
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).首个人体研究:伊立替康载药微球(DEBIRI)治疗结直肠癌不可切除肝转移。
Int J Oncol. 2012 Oct;41(4):1213-20. doi: 10.3892/ijo.2012.1572. Epub 2012 Jul 25.
8
Current status of embolic agents for liver tumor embolization.肝肿瘤栓塞用栓塞剂的现状。
Int J Clin Oncol. 2012 Aug;17(4):306-15. doi: 10.1007/s10147-012-0445-1. Epub 2012 Jul 18.
9
Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.伊立替康载药微球治疗同期全身氟尿嘧啶和奥沙利铂化疗的初治不可切除结直肠癌肝转移:药代动力学和 I 期临床试验结果。
J Gastrointest Surg. 2012 Aug;16(8):1531-8. doi: 10.1007/s11605-012-1892-8. Epub 2012 Apr 24.
10
Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.载伊立替康的载药微球(DEBIRI)经动脉内灌注与静脉内治疗(FOLFIRI)用于结直肠癌肝转移:一项 III 期研究的最终结果。
Anticancer Res. 2012 Apr;32(4):1387-95.

结直肠癌肝转移的非手术治疗方法。

Non-operative therapies for colorectal liver metastases.

作者信息

Nosher John L, Ahmed Inaya, Patel Akshar N, Gendel Vyacheslav, Murillo Philip G, Moss Rebecca, Jabbour Salma K

机构信息

1 Department of Radiology, Rutgers-Robert Wood Johnson Medical School, New Bruswick, NJ, USA ; 2 Department of Radiation Oncology, 3 Division of Medical Oncology, Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA.

出版信息

J Gastrointest Oncol. 2015 Apr;6(2):224-40. doi: 10.3978/j.issn.2078-6891.2014.065.

DOI:10.3978/j.issn.2078-6891.2014.065
PMID:25830041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4311101/
Abstract

Locoregional therapies for colorectal liver metastases complement systemic therapy by providing an opportunity for local control of hepatic spread. The armamentarium for liver-directed therapy includes ablative therapies, embolization, and stereotactic body radiation therapy. At this time, prospective studies comparing these modalities are limited and decision-making relies on a multidisciplinary approach for optimal patient management. Herein, we describe multiple therapeutic non-surgical procedures and an overview of the results of these treatments.

摘要

结直肠癌肝转移的局部区域治疗通过提供局部控制肝转移的机会来补充全身治疗。肝导向治疗的手段包括消融治疗、栓塞和立体定向体部放射治疗。目前,比较这些治疗方式的前瞻性研究有限,决策依赖多学科方法以实现最佳的患者管理。在此,我们描述多种非手术治疗方法及其治疗结果概述。